Retatrutide (GGG Tri-agonist, LY3437943) is a novel research peptide that functions as a GLP-1/GIP/glucagon tri-agonist. This lyophilized powder has shown significant potential in preliminary studies related to metabolic disorders including obesity and type 2 diabetes.
The compound demonstrates enhanced efficacy compared to similar peptides like tirzepatide and semaglutide in research settings. When combined with proper dietary and lifestyle interventions, retatrutide may offer improved outcomes in metabolic regulation studies.
Our research-grade retatrutide is provided as a sterile lyophilized powder in sealed vials to maintain stability and purity. Each batch undergoes rigorous quality control testing to ensure consistent performance in laboratory applications.
This product is intended for research purposes only in controlled laboratory environments. Proper handling procedures should be followed by qualified researchers when working with peptide compounds.